BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis

BACKGROUND: Obesity is increasingly prevalent in pulmonary arterial hypertension (PAH) but is associated with improved survival, creating an “obesity paradox” in PAH. It is unknown if the improved outcomes could be attributable to obese patients deriving a greater benefit from PAH therapies. RESEARC...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Breanne E., McClelland, Robyn L., Appleby, Dina H., Moutchia, Jude S., Minhas, Jasleen K., Min, Jeff, Mazurek, Jeremy A., Smith, K. Akaya, Fritz, Jason S., Pugliese, Steven C., Urbanowicz, Ryan J., Holmes, John H., Palevsky, Harold I., Kawut, Steven M., Al-Naamani, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2022
Materias:
Pulmonary Vascular: Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470735/
https://www.ncbi.nlm.nih.gov/pubmed/35247393
http://dx.doi.org/10.1016/j.chest.2022.02.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470735/
https://www.ncbi.nlm.nih.gov/pubmed/35247393
http://dx.doi.org/10.1016/j.chest.2022.02.041

Ejemplares similares